DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer

Background: Biomarkers predicting response to bevacizumab in breast cancer are still missing. Since epigenetic modifications can contribute to an aberrant regulation of angiogenesis and treatment resistance, we investigated the influence of DNA methylation patterns on bevacizumab efficacy. Methods:...

詳細記述

保存先:
書誌詳細
出版年:Theranostics
主要な著者: Gampenrieder, Simon Peter, Rinnerthaler, Gabriel, Hackl, Hubert, Pulverer, Walter, Weinhaeusel, Andreas, Ilic, Suzana, Hufnagl, Clemens, Hauser-Kronberger, Cornelia, Egle, Alexander, Risch, Angela, Greil, Richard
フォーマット: Artigo
言語:Inglês
出版事項: Ivyspring International Publisher 2018
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928889/
https://ncbi.nlm.nih.gov/pubmed/29721079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.23544
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料